Results of Endovascular Treatment for Infrapopliteal Arterial Occlusive Disease.
NCT ID: NCT06009146
Last Updated: 2023-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
3000 participants
OBSERVATIONAL
2023-07-01
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Revascularization for Symptomatic Non-acute Carotid Artery Occlusion
NCT06303414
Clinical Study of Stent Versus Direct Atherectomy to Treat Arteriosclerosis Occlusive Disease of Lower Extremity
NCT02840786
This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.
NCT05391815
The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.
NCT04861506
Clinical Study of Stent Versus Direct Atherectomy to Treat Lower Limb Ischemia
NCT02514460
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Rutherford scale < 4
Endovascular treatment
Endovascular treatment for infrapopliteal arterial disease.
Rutherford scale 4-5
Endovascular treatment
Endovascular treatment for infrapopliteal arterial disease.
Rutherford scale 6
Endovascular treatment
Endovascular treatment for infrapopliteal arterial disease.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endovascular treatment
Endovascular treatment for infrapopliteal arterial disease.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University Third Hospital
OTHER
Peking University First Hospital
OTHER
Beijing Hospital
OTHER_GOV
Hospital of Chengdu University of Traditional Chinese Medicine
UNKNOWN
The First Affiliated Hospital of Dalian Medical University
OTHER
Huashan Hospital
OTHER
Shanghai Pudong Hospital
OTHER
Shanghai Zhongshan Hospital
OTHER
The First Affiliated Hospital of Guangzhou Medical University
OTHER
Changhai Hospital
OTHER
Hebei General Hospital
OTHER
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
OTHER
LanZhou University
OTHER
The Second Hospital University of South China
OTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
OTHER
The Affiliated Hospital of Qingdao University
OTHER
Qingdao Haici Hospital
OTHER
Beijing Tsinghua Changgeng Hospital
OTHER
First Hospital of Tsinghua University
OTHER
Shanxi Provincial People's Hospital
OTHER_GOV
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
OTHER
RenJi Hospital
OTHER
The Luhe Teaching Hospital of the Capital Medical University
OTHER
Beijing Friendship Hospital
OTHER
Second Affiliated Hospital of Soochow University
OTHER
Tianjin First Central Hospital
OTHER
Tianjin Medical University General Hospital
OTHER
Renmin Hospital of Wuhan University
OTHER
First Affiliated Hospital Xi'an Jiaotong University
OTHER
First Affiliated Hospital of Xinjiang Medical University
OTHER
Zhejiang University
OTHER
The First Affiliated Hospital of Zhengzhou University
OTHER
Chinese Academy of Medical Sciences, Fuwai Hospital
OTHER
Xiyuan Hospital of China Academy of Chinese Medical Sciences
OTHER
Xiangya Hospital of Central South University
OTHER
First Affiliated Hospital of Chongqing Medical University
OTHER
Xuanwu Hospital, Beijing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lianrui Guo, M.D.
Role: STUDY_CHAIR
Xuanwu Hospital, Beijing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IPOD-Real Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.